Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006

被引:52
|
作者
Yang, Yun-Liang [2 ]
Wang, An-Huei [1 ]
Wang, Chih-Wei [1 ]
Cheng, Wei-Ting [1 ]
Li, Shu-Ying [3 ]
Lo, Hsiu-Jung [1 ]
机构
[1] Natl Hlth Res Inst, Div Clin Res, Zhunan Town 350, Miaoli Cty, Taiwan
[2] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu 300, Taiwan
[3] Ctr Dis Control, Div Lab Res & Dev, Taipei 115, Taiwan
关键词
Candida; susceptibility; resistance;
D O I
10.1016/j.diagmicrobio.2008.01.011
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Susceptibilities to amphotericin B and fluconazole of 964 Candida isolates collected in Taiwan Surveillance of Antimicrobial Resistance of Yeasts in 2006 were determined. There were 419 (43.5%) Candida albicans, 246 (25.5%) Candida tropicalis, 211 (21.9%) Candida glabrata, 62 (6.4%) Candida parapsilosis, 14 (1.5%) Candida krusei, and 12 (1.2%) others. Interestingly, 16 of the 17 amphotericin B-resistant isolates were non-albicans Candida species. The resistant rate to amphotericin B has decreased from 2.5% in 2002 to 1.8% in 2006. On the other hand, there were 132 C. tropicalis, 14 C. krusei, 10 C. albicans, and 9 C. glabrata isolates that had MICs to fluconazole >= 64 mu g/mL. The prevalence of isolates with such high MICs was significantly higher than that in 2002 (17.1% versus 1.9%). Our results further indicate that most of the isolates with MICs to fluconazole >= 64 mu g/mL exhibited the "trailing" phenomenon. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:175 / 180
页数:6
相关论文
共 50 条
  • [41] Mechanism of fluconazole resistance in Candida vulturna, a member of the Candida haemulonii complex of multidrug - resistant yeasts
    Macedo, Daiana
    Berrio, Indira
    Scandon, Patricia
    Gamarra, Soledad
    Effron, Guillermo Garcia
    MEDICAL MYCOLOGY, 2022, 60 (SUPP 1) : 15 - 15
  • [42] In vitro susceptibility testing of various Candida species to flucytosine-fluconazole and flucytosine-amphotericin B combinations
    Bertout, S
    Lebecq, JC
    Bastide, JM
    Mallié, M
    JOURNAL DE MYCOLOGIE MEDICALE, 2002, 12 (04): : 157 - 162
  • [43] Synergistic effects of geldanamycin with fluconazole are associated with reactive oxygen species in Candida tropicalis resistant to azoles and amphotericin B
    Jia, Chang
    Zhang, Jian
    Zhuge, Yingzhi
    Xu, Ke
    Liu, Jiahui
    Wang, Jinle
    Li, Lei
    Chu, Maoping
    FREE RADICAL RESEARCH, 2019, 53 (06) : 618 - 628
  • [44] In vitro efficacy of liposomal amphotericin B, micafungin and fluconazole against non-albicans Candida species biofilms
    Kawai, Akira
    Yamagishi, Yuka
    Mikamo, Hiroshige
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2015, 21 (09) : 647 - 653
  • [45] In vitro susceptibilities of Aspergillus species to voriconazole, itraconazole, and amphotericin B
    Abraham, OC
    Manavathu, EK
    Cutright, JL
    Chandrasekar, PH
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1999, 33 (01) : 7 - 11
  • [46] Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans
    Klepser, ME
    Wolfe, EJ
    Jones, RN
    Nightingale, CH
    Pfaller, MA
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (06) : 1392 - 1395
  • [47] Candida bracarensis: Evaluation of Virulence Factors and its Tolerance to Amphotericin B and Fluconazole
    Moreira, Andre
    Silva, Sonia
    Botelho, Claudia
    Sampaio, Paula
    Pais, Celia
    Henriques, Mariana
    MYCOPATHOLOGIA, 2015, 180 (5-6) : 305 - 315
  • [48] Comparison of fluconazole and amphotericin B for treatment of experimental Candida albicans endocarditis in rabbits
    Chemlal, K
    SaintJulien, L
    Joly, V
    Farinotti, R
    Seta, N
    Yeni, P
    Carbon, C
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (01) : 263 - 266
  • [49] Antifungal activity of carvacrol in combination with fluconazole or amphotericin B against Candida albicans
    Khodavandi, Alireza
    Alizadeh, Fahimeh
    Alizadeh, Eskandar
    MALAYSIAN JOURNAL OF MICROBIOLOGY, 2018, 14 (05) : 356 - 363
  • [50] COMPARISON OF FLUCONAZOLE AND AMPHOTERICIN-B FOR PREVENTION AND TREATMENT OF EXPERIMENTAL CANDIDA ENDOCARDITIS
    WITT, MD
    BAYER, AS
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (12) : 2481 - 2485